{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit confusing. Let me look again.\n\nThe context has four entries. The first three are just the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\". The fourth entry has the same title but the passage is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's a formatting issue here. The user probably intended to provide a passage explaining lockdowns, but it's fragmented.\n\nGiven that, I need to answer the question based on the context provided. Since the context mentions \"lockdown\" in the title and the passage, even though the content is incomplete, I can infer that a lockdown is a measure implemented to control the spread of a disease, like during a pandemic. The mention of \"non-lockdown\" in the title suggests that the study compares lockdowns to no lockdowns. The date 24/3/2020 might refer to when the lockdown was implemented, possibly in a specific country.\n\nSo, putting it together, a lockdown is a public health measure where people are required to stay at home, non-essential businesses close, and movement is restricted to prevent the spread of an infectious disease. The context implies that lockdowns are used to estimate their impact on reducing infections compared to not having them. Since the user wants the answer based on the context, I should focus on that, even though the context is minimal. I should avoid adding external knowledge beyond what's given here.\n</think>\n\nA lockdown is a public health measure implemented to restrict movement and gatherings of people, typically during a pandemic or outbreak, to reduce the spread of infectious diseases. Based on the context provided, it appears to be discussed in relation to estimating its impact on controlling infections compared to non-lockdown scenarios. The mention of \"banned Implemented with lockdown.57 24/3/2020\" suggests it was enforced as a policy on March 24, 2020, likely in response to a health crisis.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. The context provided includes two passages. \n\nFirst, looking at the first passage: it mentions that mothers infected long before delivery had only three fetal deaths. But the second passage by Gerardin et al. talks about transmission during the perinatal period leading to high morbidity. The neonates showed symptoms by day 4, had common CHIKF symptoms (which I think is Chikungunya Fever), and six had meningoencephalitis. Another study reported 19 cases of neonatal infection from maternal viremia during childbirth, leading to encephalitis via vertical transmission.\n\nSo the complications here are fetal deaths, neonatal infections, meningoencephalitis, and encephalitis. The answer should list these. Need to make sure I didn't miss any other complications mentioned. The first passage's fetal deaths are from infection long before delivery, while the others are from perinatal transmission. Both are complications. Also, the high morbidity mentioned is a general term, but the specific complications are the ones listed. I should present them clearly.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include **neonatal infections**, **meningoencephalitis**, **encephalitis**, and **fetal deaths**. These arise primarily through vertical transmission from infected mothers to their offspring, either during the perinatal period or due to intrapartum maternal viremia. Neonates may exhibit symptoms such as chikungunya fever (CHIKF) and develop severe neurological conditions like encephalitis, with some cases progressing to fatal outcomes.",
      "retrieved_chunks": [
        "Passage: and complications.",
        "Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported .",
        "Passage: A similar study by Gerardin et al.",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the passages, I notice that the main clades mentioned are 1C, 1B, 1A.1, and 1A.1.1. There's also mention of \"Other-Avian\" clades. However, there's no explicit mention of \"Clade A\" in the given passages. \n\nWait, maybe there's a typo or misunderstanding. The user might be referring to a clade that's part of the 1A lineage, like 1A.1 or 1A.1.1. The first passage mentions within-clade exceptions for 1A.1 and 1A.1.1. The second passage talks about the 1C lineage having 315 viruses from China and South Korea. The 1B lineage is mentioned in the first passage with APDs in Table 3.\n\nSince the question is about Clade A, but the context doesn't mention Clade A directly, perhaps the answer is that Clade A isn't mentioned here. Alternatively, maybe the user is confusing the numbering. The 1A.1 and 1A.1.1 are subclades under 1A. The passage says that within-clade exceptions were made for 1A.1 and 1A.1.1. But the question is about Clade A, not 1A.1. \n\nGiven that the provided context doesn't mention Clade A, the answer might be that there's no information provided about Clade A in the given passages. Alternatively, if the user meant 1A.1, then the answer would be about those specific clades. But since the question is specifically about Clade A, and the context doesn't refer to it, the correct answer would be that the information isn't available here.\n</think>\n\nThe provided context does not mention a \"Clade A.\" Instead, it references clades such as **1A.1**, **1A.1.1**, **1B**, **1C**, and **Other-Avian** within the H1 hemagglutinin gene lineage of swine influenza A viruses. For example:  \n- **1A.1** and **1A.1.1** are subclades under the",
      "retrieved_chunks": [
        "Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 ."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the context provided. The passage mentions that the S2 subunit of 2019-nCoV is highly conserved with 99% identity to the bat SARS-like CoVs and human SARS-CoV. But the question is about the S1 subunit.\n\nLooking further, the passage states that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. However, there's a part about the core domain of the RBD (receptor binding domain) being highly conserved. But then it contrasts that with the external subdomain of the Spike's RBD in 2019-nCoV having only 40% amino acid identity with other SARS-related coronaviruses.\n\nSo, putting this together: the S1 subunit's overall identity is 70%, but specific regions like the external RBD subdomain have lower identity (40%). The answer should mention both the 70% identity for the S1 subunit in general and the lower 40% in the external RBD part. Also, note that unlike S2, S1 isn't as conserved. The answer should clarify that while the core RBD is conserved, the external part isn't. The user might be confused about the difference between S1 and S2 subunits here, so the answer needs to address both the overall S1 identity and the specific RBD regions.\n</think>\n\nThe S1 subunit of 2019-nCoV shares **around 70% identity** with the S1 subunits of the two bat SARS-like CoVs and human SARS-CoV. However, while the **core domain of the receptor binding domain (RBD)** in the S1 subunit is highly conserved, the **external subdomain of the Spike\u2019s RBD** in 2019-nCoV exhibits significantly lower conservation, with only **40% amino acid identity** compared to other SARS-related coronaviruses. This contrasts with the S2 subunit, which shows much higher",
      "retrieved_chunks": [
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses."
      ],
      "computed_relevance": 0.6,
      "computed_utilization": 0.6,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" I need to base my answer on the provided context.\n\nFirst, I'll look through the passages given. The first one mentions that Bacillus species are found near decomposing plants. Then there's a part about Bacillus subtilis producing surfactins, fengycins, and iturins in specific ratios. That seems important because it shows they produce certain compounds, maybe with antimicrobial properties?\n\nThe second passage talks about Bacillus and Lactobacillus being in traditional fermented foods and used as probiotics. Examples like Enterogermina and Biosubtyl are listed. So Bacillus subtilis is a probiotic, used in commercial products. Also, in the food industry, they're used as starter cultures for things like yogurt and cheese.\n\nThe third passage says that Bacillus species, unlike Lactobacillus, weren't considered part of the normal intestinal microbiome. But when isolated from feces, Bacillus subtilis helps restore gut balance by increasing beneficial bacteria like Bifidobacterium and Lactobacillus, and reducing harmful ones like Clostridium. So it's a probiotic that helps gut health.\n\nPutting this together: Bacillus subtilis is a species of Bacillus found in environments like decomposing plants. It's used in probiotics and fermented foods. It produces antimicrobial substances which help in maintaining gut health by promoting good bacteria and inhibiting harmful ones. The key points are its role in probiotics, the substances it produces, and its effect on gut microbiota balance.\n\nI need to make sure I don't add any external info. The answer should be concise, mentioning its presence in nature, its use in probiotics/food, and its beneficial effects on the gut. Also, the specific compounds it produces (surfactins, fengycins, iturins) in the given ratio might be worth mentioning to show its mechanism of action.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus commonly found in environments such as decomposing plant material. It is a probiotic bacterium historically used in traditional fermented foods and modern commercial probiotic products (e.g., Enterogermina, Biosubtyl) to support intestinal health. It produces antimicrobial compounds like surfactins, fengycins, and iturins (",
      "retrieved_chunks": [
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves, but the user is interested in single-wave pandemics. However, there's a part where it talks about the 1918 pandemic's herald waves possibly stretching back to 1915. But the 1918 pandemic itself is known for having multiple waves, so maybe that's not directly relevant here.\n\nNext, the second context is about the 2009 H1N1 pandemic in Hong Kong. It mentions studies on the origin of the strain and pathogenesis. However, the 2009 pandemic had multiple waves too, so not sure if this fits.\n\nThe third context discusses economic analysis of mitigation strategies for different pandemic severities. It references previous studies using simulation models but doesn't specifically mention single-wave pandemics. The focus here is more on strategies and severity categories rather than past pandemics' wave patterns.\n\nThe fourth context is about influenza virus circulation in Taiwan, 2008-2014, focusing on the 2009 pH1N1 pandemic. It talks about multi-wave epidemics and models like the Richards model. Again, the 2009 pandemic had multiple waves, so this might not fit the single-wave criteria.\n\nWait, the user is asking about severe, single-wave pandemics. The first context mentions the 1889 pandemic had three waves, but maybe there's a mention of other pandemics? The first passage starts by discussing the 1889 pandemic's three waves and then mentions the 1918 pandemic's herald waves. However, the 1918 pandemic is known for having multiple waves as well. The user is looking for research on single-wave pandemics, so maybe the 1889 pandemic isn't the example here. But the context doesn't mention any single-wave pandemics directly.\n\nLooking again, the third context's passage says that the current study extends previous models by considering five pandemic severity categories and varying interventions. It references studies by Sander et al., Perlroth et al., etc., which used individual-based simulation models. However, these studies are about mitigation strategies",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.75,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the given context. The user is asking for the number of reported viral pneumonia cases, so I need to look through the provided passages to find any mention of that.\n\nFirst, looking at the first passage titled \"Clinical review: Primary influenza viral pneumonia,\" it talks about bacterial co-infection in the 2009 H1N1 pandemic. It mentions 77 fatal cases of pandemic H1N1v 2009 infection with 29% having concurrent bacterial pneumonia. But the question is about viral pneumonia, not bacterial. So maybe this isn't directly relevant, but it does mention primary influenza viral pneumonia. However, the number here is about bacterial co-infection, not the total viral pneumonia cases. So maybe not the answer here.\n\nNext, the second passage is about the 2019-nCoV (which is COVID-19). It states that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection. This seems like a direct mention of viral pneumonia cases caused by a novel coronavirus. The question is about \"reported viral pneumonia,\" so this could be the number they're looking for. The passage also mentions 461 severe cases and 80 deaths, but the total confirmed cases are 2744.\n\nThe third passage is about pneumonia in adults with seasonal influenza in the US from 2005\u20132008. It mentions that patients with pneumonia were more likely to receive antiviral therapy. But it doesn't give specific numbers of cases, just percentages. So probably not the answer here.\n\nThe fourth passage again mentions 51 cases cured and discharged, 5794 suspected cases, etc. But this seems to be part of the same context as the second passage, likely related to the 2019-nCoV. The 2744 confirmed cases from the second passage would be the main number here. The other numbers like 5794 suspected or 30,453 under observation are about tracking contacts and suspected cases, but the confirmed cases are 2744.\n\nThe other passage about the 2009 H1N1 mentions attack rates but not specific numbers of viral pneumonia cases beyond the 7",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age ."
      ],
      "computed_relevance": 0.1111111111111111,
      "computed_utilization": 0.1111111111111111,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The passage also mentions that MERS-CoV was the first to have such widespread use of deep sequencing for studying an emerging viral outbreak. \n\nI should check the other passages to see if there's any conflicting information. The second passage talks about genetic recombination and studies from 2015, but doesn't mention the method used. The third passage discusses genome analyses focusing on specific regions like the spike protein, but again, the method isn't specified there. The fourth passage mentions subgenomic sequencing but says it's been less published during MERS-CoV, implying that other methods were more common. \n\nSo the key point from the first passage is high throughput or deep sequencing. The answer should reflect that. I need to make sure I'm not missing any other methods mentioned. The answer should be concise, quoting the main method stated in the first passage.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur .",
        "Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first passage: They mention using an inverted fluorescence microscope to monitor plates until they saw GFP expression. That's about initial detection, but maybe not tracking spread.\n\nThe second passage talks about MLV particles being concentrated and mentions mouse lines with reporter genes like EGFP and mCherry. Also, there's a note about adoptively transferring fluorescent cells into donor mice for imaging. But the key part here might be the third passage.\n\nIn the third passage, it says that in infected mice, GFP was observable in the lungs ex vivo using IVIS for whole-organ imaging. Also, flow cytometry was used to analyze infection progression in antigen-presenting cells. The imaging showed the infection starting near large airways and spreading deeper. Additionally, there's mention of long-term tracking possible due to strong fluorescent protein expression without bleaching.\n\nSo putting it together, the methods used were IVIS for whole-organ imaging and flow cytometry. The answer should include both techniques. Let me check if there are other methods mentioned. The first context used a microscope, but that was during initial monitoring in plates. The third context's methods are more about tracking spread in vivo. So the answer is IVIS and flow cytometry.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **whole-organ imaging with IVIS (in vivo imaging system)** to observe GFP in the lungs of infected mice ex vivo, and **flow cytometry** to analyze infection progression in antigen-presenting cells. Additionally, the strong and continuous expression of fluorescent proteins allowed long-term tracking without significant bleaching.",
      "retrieved_chunks": [
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "Many different mouse lines are available that contain reporter genes for cytoplasmic fluorescent proteins such as EGFP and mCherry .",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since it's after a suspected case, maybe they mean that even though the patient is suspected, the CT is disinfected regardless. \n\nThe answer should probably include steps like immediate disinfection after the exam, using specific sterilization procedures. The context doesn't go into detailed steps, but the main idea is that the equipment is disinfected right after the examination. So the answer would be that the recommended procedure is to disinfect the CT scanner immediately after the examination using established sterilization protocols. I need to make sure I don't add any extra steps not mentioned in the context. The repetition of \"immediately after the examination\" and \"disinfect the imaging equipment\" in the context supports that.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment after the examination** using established sterilization protocols. The context emphasizes that this process should occur promptly following the examination of a suspected or confirmed COVID-19 case to prevent contamination. Specific steps include preparing the equipment for disinfection and adhering to noncontaminated CT disinfection procedures as outlined in emergency management guidelines.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}